A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants
Clinical trial NCT05959109 · COMPLETED
Trial details
- NCT number
- NCT05959109
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-21
- Primary completion
- 2024-01-11
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.